ArticleBreast cancer research and treatment2014

Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.

Aleksandra Filipović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.